Health System, Biotech Collaborate on Diagnostic Biomarkers

Luminex Corporation in Austin, Texas said today that is teaming with Partners HealthCare in Boston, Massachusetts on the discovery of new biomarkers and development of clinical assays. The collaboration is expected to help the Partners HealthCare Center for Personalized Genetic Medicine (PCPGM) develop new molecular diagnostic assays.

The new tests will be conducted on Luminex’s xMAP testing platform. The xMAP platform delivers bioassay results for pharmaceutical drug discovery, clinical diagnostics, and biomedical research, including the genomics and proteomics markets. Under the terms of the agreement, Luminex and PCPGM will evaluate opportunities for new assays, which will be developed and validated in the PCPGM’s Laboratory for Molecular Medicine.

Partners HealthCare is an extensive biomedical research organization and health system founded by Brigham and Women’s Hospital and Massachusetts General Hospital, and a principal teaching affiliate of Harvard Medical School.

*     *     *